Latest news
Ractigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMTDyne Therapeutics Announces U.S. FDA Clearance of Investigational New Drug (IND) Application for DYNE-302 in Facioscapulohumeral Muscular Dystrophy (FSHD) - Yahoo Finance SingaporeYahoo Finance Singapore · Tue, 28 Jul 2026 11:30:00 GMT